Pricing

Log inSign up

Synklino

1 follower

‌

Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.

Industries

Biotechnology, Health Care

Headquarters

Lyngby, Denmark

Employees

11-50

Links

Org chart

Thomas Kledal
CEO & Co-Founder
Collapse
Mads Jeppesen
CMC Project Director & Co-Founder
Jette Wagtberg Sen
COO
Carit Jacques Andersen
CFO
Josefin-Beate Holz
CMO
MJ
Mads Gravers Jeppesen
Head of Discovery
SN
Søren Neve
Head of Pharmacology
IM
Ian McGowan
Chief Medical Officer

Board & advisors

Mette Rosenkilde
Co-Founder & Board Member
John Haurum
Chairman
Morten Schrøder
Board Member
Magnus Persson
Board Member
Thomas Feldthus
Board Member
Christine Flarup Møller-Jensen
Board Member
Mads Lacoppidan
Board Member
John Sinclair
Scientific Advisor
John Lambert
Scientific Advisor
Atul Humar
Scientific Advisor

Teams

+6

Board of Directors

10 people · 0 jobs

+2

Leadership Team

6 people · 0 jobs

AD
MJ
SN

Scientific Team

4 people · 0 jobs

Advisory Team

3 people · 0 jobs

Offices

Similar companies

Bavarian Nordic

8 followers

Tango Therapeutics

3 followers

Merck

277 followers

Cellares

4 followers

Function Health

10 followers

Revvity

8 followers

Visma Dinero

33 followers

Sanofi

279 followers

Gilead Sciences

157 followers

Regeneron

124 followers

AtriCure

4 followers

Explore companies